Cyproheptadine Hydrochloride Tablet
Product Images NDC 70752-107

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 70752-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quagen Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Chemsture)

This text appears to be a chemical notation, indicating the molecular weight of a compound as 350.89 g/mol. However, without additional context or information, it is not possible to determine the identity or significance of the compound.*

FDA Label Image

Principal Display Panel (1000 Tablets Bottle Label)

Quagen Pharmaceuticals offers tablets containing 4 mg of cyproheptadine hydrochloride, which is a USP-approved medication. For full prescribing information, see the package insert. The tablets should be kept in a well-closed container with a child-resistant closure, out of the reach of children, and stored at a USP-controlled room temperature of 20° to 25°C (68° to 77°F). The tablets are supplied in a bottle of 1000 tablets.*

FDA Label Image

Principal Display Panel (100 Tablets Bottle Label)

This is a description of a medication called Cyproheptadine HCI Tablets. Each tablet contains 4mg of cyproheptadine HCI USP and must be stored at a temperature controlled room. The usual dosage should be followed as described in the package insert. The medication is manufactured by Quagen Pharmaceuticals LLC in West Caldwell, NJ. The label indicates the product code as NDC 7075210710 and there is a cautionary statement advising people to keep the medication out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.